Back to top

Image: Bigstock

Should You Buy Horizon Pharma PLC (HZNP) Ahead of Earnings?

Read MoreHide Full Article

Investors are always looking for stocks that are poised to beat at earnings season and Horizon Pharma PLC may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because Horizon Pharmais seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings—with the most up-to-date information possible—is a pretty good indicator of some favorable trends underneath the surface for HZNP in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at 26 cents per share for HZNP, compared to a broader Zacks Consensus Estimate of 25 cents per share. This suggests that analysts have very recently bumped up their estimates for HZNP, giving the stock a Zacks Earnings ESP of 4.00% heading into earnings season.

Horizon Pharma PLC Price and EPS Surprise
 

Horizon Pharma PLC Price and EPS Surprise | Horizon Pharma PLC Quote

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10 year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that HZNP has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Clearly, recent earnings estimate revisions suggest that good things are ahead for Horizon Pharma, and that a beat might be in the cards for the upcoming report.

Zacks' 2017 IPO Watch List

 Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.

One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>
 

Published in